BGN is highly expressed in multiple tumors, including pancreatic cancer, esophageal cancer, gastric cancer, colon cancer, endometrial cancer and prostate cancer, and transcriptional analysis also revealed that BGN is a promising diagnostic and therapeutic target in different cancers [30,40] . This evidence concerns the gene BGN and prostate carcinoma.